Takayuki Yamada

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Skeletal Muscle

Combination Therapy

African American

Top Venues

Diabetes, obesity & metabolism

Journal of the American Society of Nephrology : JASN

International journal of clinical practice

International urology and nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Shunichiro Tsukamoto, Shohei Tanaka, Takayuki Yamada, Kazushi Uneda, Kengo Azushima, Sho Kinguchi, Hiromichi Wakui, Kouichi Tamura
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism (2023)
Ryutaro Morita, Shunichiro Tsukamoto, Shota Obata, Takayuki Yamada, Kazushi Uneda, Tatsuki Uehara, Muhammad Ebad Rehman, Kengo Azushima, Hiromichi Wakui, Kouichi Tamura
Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients. Diabetes, obesity & metabolism (2023)
Takayuki Yamada, Chethan M Puttarajappa, Csaba P Kovesdy, Yoshitsugu Obi
A Specific Target BP in Chronic Kidney Disease Remains Unclear. Journal of the American Society of Nephrology : JASN 34 (6) (2023)
Ryutaro Morita, Shunichiro Tsukamoto, Shota Obata, Takayuki Yamada, Kazushi Uneda, Tatsuki Uehara, Muhammad Ebad Rehman, Kengo Azushima, Hiromichi Wakui, Kouichi Tamura
Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients. Diabetes, obesity & metabolism (2023)
Takayuki Yamada, Takahisa Mikami, Nitin Chopra, Hirotaka Miyashita, Svetlana Chernyavsky, Satoshi Miyashita
Is there a racial disparity in coronavirus disease 2019 patients with chronic kidney disease? An experience in New York City. International journal of clinical practice 75 (7) (2021)
Takayuki Yamada, Takahisa Mikami, Nitin Chopra, Hirotaka Miyashita, Svetlana Chernyavsky, Satoshi Miyashita
Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City. International urology and nephrology 52 (7) (2020)